NYSE American

Lytus Technologies (LYTHF) announced a 1-for-2,500 reverse stock split, effective September 26, 2025, aiming to increase its market price to meet NYSE American listing requirements. The company will continue trading under “LYTHF” with CUSIP number G5851A141. The split impacts all shareholders uniformly, rounding fractional shares up. VStock Transfer LLC is the transfer agent. The company focuses on platform services, including streaming, telemedicine, and fintech across India and international markets.

SunLink Health Systems received a deficiency letter from NYSE American for failing to hold its annual stockholder meeting. While its stock will continue trading, it will be flagged with a “.BC” indicator. This issue is unlikely to affect SunLink’s proposed merger with Regional Health Properties, scheduled for a shareholder vote soon. SunLink must hold its annual meeting by June 30, 2026, to regain full compliance if the merger is terminated.

On June 23, 2025, Dr Ashleys Limited and Impact BioMedical Inc. announced a merger deal. Dr. Ashleys will acquire Impact BioMedical through a reverse merger, creating a new entity listed on the NYSE American. This strategic alliance merges Impact BioMedical’s innovative patents with Dr Ashleys’ resources and global reach, aiming to expedite the development of impactful therapies and expand global market access for biomedical advancements.